Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis
暂无分享,去创建一个
G. Che | Cheng Shen | Da-li Chen | Yubin Zhou | H. Du
[1] Xuelei Ma,et al. Prognostic role of caveolin in breast cancer: a meta-analysis. , 2013, Breast.
[2] H. Lee,et al. Caveolin 1 Expression Correlates with Poor Prognosis and Focal Adhesion Kinase Expression in Gastric Cancer , 2012, Pathobiology.
[3] M. Toi,et al. Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer , 2012, Medical Oncology.
[4] Li-ke Yu,et al. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas , 2011, Oncology reports.
[5] V. Adam,et al. Caveolin-1 as a potential high-risk prostate cancer biomarker. , 2011, Oncology reports.
[6] J. Serth,et al. Caveolin 1 protein expression in renal cell carcinoma predicts survival , 2011, BMC urology.
[7] F. Sotgia,et al. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment , 2011, Breast Cancer Research.
[8] Hong Chen,et al. Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma. , 2011, Oncology reports.
[9] L. Roncuzzi,et al. 499 Metastatic lung cancer proliferation is inhibited by Caveolin-1 silencing , 2010 .
[10] L. Diao,et al. Caveolin-1 and VEGF-C promote Lymph Node Metastasis in the Absence of Intratumoral Lymphangiogenesis in Non-small Cell Lung Cancer , 2010, Tumori.
[11] Jun-quan Yang,et al. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer]. , 2008, Zhonghua bing li xue za zhi = Chinese journal of pathology.
[12] Y. Fujii,et al. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. , 2007, Oncology reports.
[13] Juanhan Yu,et al. [Significance of caveolin-1 expression in primary lung cancer]. , 2006, Zhonghua bing li xue za zhi = Chinese journal of pathology.
[14] K. Moon,et al. Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. , 2005, Anticancer research.
[15] M. Lisanti,et al. Caveolin-1 in oncogenic transformation, cancer, and metastasis. , 2005, American journal of physiology. Cell physiology.
[16] S. Okushiba,et al. Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma. , 2004, Cancer letters.
[17] Yoon-La Choi,et al. Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. , 2003, Lung cancer.
[18] J. Minna,et al. P-295 Dramatically different roles for caveolin-1 in the development of Non-Small Cell Lung Cancer (NSCLC) vs. Small Cell Lung Cancer (SCLC) , 2003 .
[19] Pan‐Chyr Yang,et al. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. , 2002, The American journal of pathology.
[20] S. Woodman,et al. Caveolae: From Cell Biology to Animal Physiology , 2002, Pharmacological Reviews.
[21] R. Cardiff,et al. Mammary Disease Mice Model Premalignant Polyoma Middle-T Transgenic Updated Version , 2001 .
[22] M. Lisanti,et al. Caveolin-1 Binding to Endoplasmic Reticulum Membranes and Entry into the Regulated Secretory Pathway Are Regulated by Serine Phosphorylation , 2001, The Journal of Biological Chemistry.
[23] A. Quest,et al. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. , 2000, Cancer research.
[24] C. Londos,et al. The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets. , 2000, Biochimica et biophysica acta.
[25] M. Parmar,et al. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.
[26] J. Engelman,et al. Targeted downregulation of caveolin‐1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade , 1998, The EMBO journal.
[27] J. Engelman,et al. Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo , 1998, FEBS letters.
[28] D. Bostwick,et al. A molecular cytogenetic analysis of 7q31 in prostate cancer. , 1997, Cancer research.
[29] Charles C. Wykoff,et al. Recombinant Expression of Caveolin-1 in Oncogenically Transformed Cells Abrogates Anchorage-independent Growth* , 1997, The Journal of Biological Chemistry.
[30] S. S. Koh,et al. Baculovirus-based Expression of Mammalian Caveolin in Sf21 Insect Cells , 1996, The Journal of Biological Chemistry.
[31] M. Lisanti,et al. Co-purification and Direct Interaction of Ras with Caveolin, an Integral Membrane Protein of Caveolae Microdomains , 1996, The Journal of Biological Chemistry.
[32] C. Begg,et al. Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.
[33] R. F. Cook,et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease , 1994, The Journal of cell biology.
[34] M. Zheng,et al. Expression of Caveolin-1 and its significance in the prognosis of lung squamous cell carcinoma , 2013 .
[35] Chih-Hsin Yang,et al. Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy. , 2008, Lung cancer.